Comparing the Two Top Stocks: Harris Corporation (NYSE:HRS), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

earning reaction history, nasdaq, nyse

Harris Corporation (NYSE:HRS)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) closed at $40.24 on the last trading session with an decrease of -3.15%, whereas, it previously closed at $41.55. The company has a market capitalization of $6.31 Billion. The company traded shares of 1.15 Million on the trading day while its three month average volume stands at 1.59 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) produced diluted EPS of -1.76. The EPS estimate for next year as estimated by analysts is at -1.29 while EPS for next quarter is estimated at -0.36. Earnings per Share growth for this year is reported at -7.7, while the analysts estimated the EPS growth for next year at -1.29% and Earnings growth for next 5 years stands at 26.5% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -34.3%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands at 21.03 and Price to Book or P/B for the most recent quarter stands at 8.53. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) are reported at 10.9 and 11 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands at -43.7, -50.2 and -51.9 respectively

The trailing twelve month Revenue of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is reported at 300.3 Million with income of -247700000. The outstanding shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) are 156.93 Million. The institutional Ownership of the shares of 95.6 stands at 0.80%, this figure is increased 0.22 in the last six months. The insider ownership for the shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is ticked at 0.09%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is the Mean Target Price estimated by the analysts which stands at 55.8. The 52 week high of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is placed at 53.70 and 52 week low is standing at 21.03.

Performance wise the shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) fell down -4.55% for the week, it also fell -8.48% for the monthly performance, while for the quarter it went up -4.53%. The shares increase 60.96% for the half year and plummeted for the Year-To-Date performance. The shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) grew 80.37% for the yearly performance.